Cervical dystonia (torticollis)

Active Ingredient: Botulinum toxin type B

Indication for Botulinum toxin type B

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

5,000 or 10,000 U every 12-16 weeks

For:

Dosage regimens

Regimen A: Intramuscular, 5,000 international units botulinum toxin type B, once every 12 to 16 weeks.

Regimen B: Intramuscular, 10,000 international units botulinum toxin type B, once every 12 to 16 weeks.

Detailed description

The initial dose is 10,000 U and should be divided between the two to four most affected muscles. Data from clinical studies suggest that efficacy is dose dependent, but these trials, because they were not powered for a comparison, do not show a significant difference between 5000 U and 10,000 U. Therefore an initial dose of 5,000 U may also be considered, but a dose of 10,000 U may increase the likelihood of clinical benefit.

Injections should be repeated as required to maintain good function and minimise pain. In long term clinical studies, the average dosing frequency was approximately every 12 weeks, however this may vary between subjects, and a proportion of patients maintained a significant improvement relative to baseline for 16 weeks or longer. The dosing frequency should therefore be adapted based on the clinical assessment/response of an individual patient.

For patients with reduced muscle mass the dose should be adjusted according to individual patient need.

The potency of this medicinal product is expressed in botulinum toxin type B 5000 U/ml. These units are not interchangeable with the units used to express the potency of other botulinum toxin preparations.

Dosage considerations

Botulinum toxin type B solution for injection must only be administered by intramuscular injection. Particular caution should be paid to ensure that it is not injected into a blood vessel.

The initial dose of 10,000 U should be divided between the two to four most affected muscles.

Active ingredient

Botulinum toxin type B

Botulinum toxin type B is a neuromuscular blocking agent indicated for the treatment of cervical dystonia. When injected directly into a muscle, it causes a localised paralysis that gradually reverses over time.

Read more about Botulinum toxin type B

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.